Second-line treatment of hepatocellular carcinoma: from theory to practical issues

Por V. V. Breder, K. K. Laktionov
Publicado em 2019-12-01

Preliminary results of retrospective analysis Atezolizumab and Bevacizumab in first-line therapy of advanced HCC

Por I. А. Dzhanyan, М. V. Natrusova, V. V. Breder
Publicado em 2021-06-01

Immunotherapy for hepatocellular cancer: beginning and future perspectives

Por M. A. Kazantseva, V. V. Breder, K. K. Laktionov
Publicado em 2019-06-01

PHARMACOLOGICAL THERAPY OF HEPATOCELLULAR CANCER PRACTICAL ISSUES AND SOLUTIONS

Por V. V. Breder, K. K. Laktionov, M. I. Davydov
Publicado em 2017-11-01

Рembrolizumab as second line therapy for hepatocellular patient

Por I. A. Dzhanyan, V. V. Breder, O. I. Borisova, K. K. Laktionov
Publicado em 2021-12-01

HEPATOCELLULAR CARCINOMA AS A SOCIAL AND MEDICAL PROBLEM IN THE RUSSIAN FEDERATION

Por V. V. BREDER, V. Y. KOSYREV, N. E. KUDASHKIN, K. K. LAKTION
Publicado em 2016-12-01

Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case

Por Yu V Bisovskaya, V V Breder, B M Medvedeva, V A Gorbunova
Publicado em 2014-06-01

Oncological care for the patients with hepatocellular carcinoma in COVID-19 pandemic

Por V. V. Petkau, V. V. Breder, E. N. Bessonova, K. K. Laktionov, I. S. Stilidi
Publicado em 2020-07-01

Immunotherapy for small-cell lung cancer

Por A. Ye. Kuzminov, K. K. Laktionov, A. A. Yegorova, V. V. Breder, T. D. Barbolina
Publicado em 2019-06-01

Clinical case of use of osimertinib in a patient with disseminated EGFR-mutated non-small cell lung cancer in the first-line therapy

Por K. A. Sarantseva, K. K. Laktionov, E. V. Reutova, D. I. Yudin, V. V. Breder
Publicado em 2020-12-01

Firsthand experience of chemoradiotherapy in patients with localized small cell lung cancer. Retrospective assessment

Por A. E. Kuzminov, T. N. Borisova, V. V. Breder, E. V. Reutova, T. D. Barbolina, K. K. Laktionov
Publicado em 2020-07-01

Fibrolamellar liver cancer: the modern concept

Por E. Yu. Antonova, V. V. Breder, E. A. Moroz, K. K. Laktionov, I. A. Dzhanyan, A. Yu. Volkov
Publicado em 2020-12-01

Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

Por K. K. Laktionov, K. A. Sarantseva, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov
Publicado em 2019-12-01

BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started

Por V. V. Breder, M. U. Pitkevich, E. R. Virshke, L. A. Kostyakova, I. A. Dzhanyan, K. K. Laktionov
Publicado em 2018-07-01

A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma

Por K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, K. P. Laktionov, V. V. Breder, E. V. Reutova
Publicado em 2018-07-01

Five-year results of nivolumab for the treatment of non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

Por D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, M. S. Ardzinba, E. V. Reutova, O. I. Borisova
Publicado em 2021-08-01

Pseudoprogression in patients on immunotherapy

Por D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba
Publicado em 2019-06-01

Experience of treatment of a patient with non-small cell lung cancer with met exon 14 skipping

Por M. O. Mandrina, V. V. Breder, M. V. Ivanov, A. A. Lebedeva, V. V. Gorbatsevich, K. K. Laktionov, P. V. Kononets
Publicado em 2021-08-01

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation

Por K. K. Laktionov, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov, D. T. Marinov, D. A. Peregudov, M. S. Ardzinba
Publicado em 2019-06-01

THE FIRST CLINICAL EXPERIENCE WITH AFATINIB IN RUSSIAN FEDERATION

Por К. К. LAKTIONOV, М. V. PEREGUDOVA, V. V. BREDER, E. V. REUTOVA, D. A. PEREGUDOV, M. S. ARDZINBA, P. A. CHERNENKO, D. T. MARINOV
Publicado em 2016-12-01